GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Research & Development

A Plus Biotechnology Co (ROCO:6918) Research & Development : NT$51.5 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. A Plus Biotechnology Co's Research & Development for the three months ended in Mar. 2025 was NT$12.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was NT$51.5 Mil.

A Plus Biotechnology Co Research & Development Historical Data

The historical data trend for A Plus Biotechnology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co Research & Development Chart

A Plus Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 79.96 63.08 77.00 59.54 53.34

A Plus Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.21 16.09 13.02 10.03 12.31

A Plus Biotechnology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$51.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A Plus Biotechnology Co  (ROCO:6918) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

A Plus Biotechnology Co Research & Development Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

A Plus Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Research & Development
Comparable Companies
TPE:6955 ROCO:4138 ROCO:6747 TPE:6796 TPE:4155 ROCO:7713 TPE:4106 ROCO:6934 ROCO:6815 TPE:6861 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN
Website
https://www.aplusbio.com
A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co Headlines

No Headlines